The presence of PD-L1 antibodies on tumor cell membranes was associated to patient prognosis, stage, and recurrence or metastasis after surgery.On the other hand, PD-L1 immunodetection of tumor-infiltrating mononuclear cells (TIMCs) has been associated to post-surgery recurrence or metastasis, as well as patient prognosis [28]. The gene discussed is CD274; the disease is neoplasm.